Atherectomy Devices Market revenue to cross USD 3.3 Billion by 2035 | Boston Scientific Corporation, Medtronic plc, Cardiovascular Systems Inc. (CSI), Philips Healthcare, Avinger Inc.

Market Outlook and Forecast

The Atherectomy Devices Market continues to gain strong traction globally as minimally invasive cardiovascular interventions become the preferred approach for treating peripheral and coronary arterial diseases. With hospitals and surgical centers increasingly adopting procedures that minimize patient downtime, atherectomy systems have emerged as essential tools for plaque removal, vessel restoration, and optimized stent placement.

Valued at USD 1.6 billion in 2025, the Atherectomy Devices Market is projected to reach USD 3.3 billion by 2035, expanding at a robust 8.4% CAGR during 2026-2035. Growing prevalence of diabetes, hypertension, and lifestyle-related vascular conditions is accelerating the demand for advanced debulking technologies worldwide. At the same time, significant investments in catheter-based systems, image-guided atherectomy, and device miniaturization continue to fuel market evolution.

➤ Request Free Sample PDF Report @ https://www.researchnester.com/sample-request-8102

Regional Performance Highlights

North America is expected to remain the leading market, commanding 48.3% share by 2035. The region's dominance stems from its high incidence of peripheral arterial disease (PAD), advanced reimbursement frameworks, and rapid adoption of novel atherectomy technologies. Growing preference among clinicians for minimally invasive plaque excision methods and expanding usage of rotational and laser systems further support market leadership.

Europe maintains its strong foothold as a significant innovation hub for vascular therapies. Countries such as Germany, the U.K., France, and Italy continue to expand atherectomy procedure volumes due to growing PAD awareness and increased investments in hybrid operating rooms. Focus on evidence-based treatment pathways and clinical guidelines encouraging endovascular procedures further enhance the market outlook.

Asia Pacific is emerging as the fastest-growing region, driven by expanding healthcare access, rising disposable incomes, and rapidly improving interventional cardiology infrastructure. China, Japan, India, and South Korea represent key hotspots where the penetration of atherectomy devices is accelerating due to rising cardiovascular disease prevalence and increasing adoption of advanced surgical technologies. Government-backed investments in medical innovation and a growing pipeline of interventional specialists amplify opportunities in the region.

➤ Gain access to expanded insights on competitive strategies, market size, and regional analysis. View our Atherectomy Devices Market Report Overview here: https://www.researchnester.com/reports/atherectomy-devices-market/8102

Market Segmentation

The peripheral vascular applications segment accounts for a dominant 78.5% share by 2035, driven by increasing PAD prevalence, especially among aging populations and diabetic patients. Atherectomy procedures are widely preferred for removing complex plaque morphologies - including calcified lesions, chronic total occlusions, and mixed plaque types - improving vessel patency and reducing restenosis risk.

Within end-use categories, the hospitals segment remains the largest consumer of atherectomy systems. Integrated cardiovascular departments, advanced imaging capabilities, and specialist availability enable hospitals to perform a high volume of plaque removal procedures. The segment also benefits from ongoing investments in hybrid ORs and robotic-assisted vascular surgery platforms.

➤ Explore the complete Atherectomy Devices Market forecast and regional insights in our detailed report. Download our sample report here → https://www.researchnester.com/sample-request-8102

Top Market Trends

1. Technological Advancements and Precision-Based Atherectomy Systems
Rapid innovations in atherectomy technology are reshaping clinical workflows and improving patient outcomes. Companies are launching devices with improved tip control, enhanced torque, and advanced imaging integration that allow clinicians to target lesions with higher precision.

Recent developments include systems equipped with real-time intravascular imaging, automated rotational speed modulation, and laser-based plaque vaporization tailored for challenging artery segments. Advanced orbital atherectomy platforms introduced in 2024-2025 provide lower embolic risk and reduced thermal damage, strengthening physician confidence in device performance.

2. Rising Adoption of Minimally Invasive and Image-Guided Vascular Procedures
Growing demand for minimally invasive treatments has accelerated the adoption of atherectomy devices in both peripheral and coronary applications. Image-guided plaque removal is gaining prominence as it enables clinicians to visualize lesion composition, optimize device selection, and ensure complete debulking.

Increasing use of fluoroscopy, IVUS, and OCT imaging during atherectomy procedures has significantly improved accuracy and minimized procedural complications. Hospitals across Europe and North America are integrating image-guided systems to support personalized interventional strategies, enhancing procedural success rates.

3. Shift Toward Device-Drug Combinations and Adjunct Therapies
The market is witnessing a strong trend toward combining atherectomy with drug-coated balloons (DCBs) or stents. This combination therapy approach is demonstrating superior long-term vessel patency, especially in calcified or complex lesions.

In 2024-2025, several clinical studies revealed improved outcomes when atherectomy devices were used before DCB deployment, leading to wider adoption by vascular specialists. Manufacturers are increasingly collaborating with drug-device companies to develop integrated treatment solutions that reduce restenosis risk and shorten recovery time.

➤ Stay ahead of the curve with the latest Atherectomy Devices Market trends. Claim your sample report → https://www.researchnester.com/sample-request-8102

Recent Company Developments

The competitive landscape of the Atherectomy Devices Market is rapidly evolving, driven by product launches, strategic partnerships, and mergers across the interventional cardiology ecosystem. Below are notable developments from the past 12 months:

1. Boston Scientific Corporation - Expanded its atherectomy portfolio with an upgraded rotational system offering enhanced plaque engagement and reduced vibration for increased procedural precision.

2. Medtronic plc - Announced a strategic R&D investment into next-generation directional atherectomy devices featuring improved embolic protection and automated cutter adjustment technologies.

3. Cardiovascular Systems, Inc. (CSI) - Launched an advanced orbital atherectomy system optimized for heavily calcified lesions, integrating improved crown design and multi-speed control capabilities.

4. Philips Healthcare - Strengthened its image-guided therapy offerings by introducing an atherectomy system with real-time vessel imaging and automated feedback for device navigation.

5. Avinger, Inc. - Expanded its lumivascular atherectomy platform with a new catheter integrating OCT imaging, enabling direct visualization of plaques during removal.

➤ Request Free Sample PDF Report @ https://www.researchnester.com/sample-request-8102

Contact Data
AJ Daniel
Corporate Sales, USA
Research Nester
77 Water Street 8th Floor, New York, 10005
Email: info@researchnester.com
USA Phone: +1 646 586 9123
Europe Phone: +44 203 608 5919

About Research Nester
Research Nester is a one-stop service provider with a client base in more than 50 countries, leading in strategic market research and consulting with an unbiased and unparalleled approach towards helping global industrial players, conglomerates and executives for their future investment while avoiding forthcoming uncertainties. With an out-of-the-box mindset to produce statistical and analytical market research reports, we provide strategic consulting so that our clients can make wise business decisions with clarity while strategizing and planning for their forthcoming needs and succeed in achieving their future endeavors. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds.

This release was published on openPR.